Consistent with GSEA findings, recombinant ASPN induced activating phosphorylation of HER2 in all prostate cancer cell lines analyzed (Figure 1H and Supplemental Figure 2, A–D). The gene discussed is ERBB2; the disease is prostate carcinoma.